Trials / Completed
CompletedNCT03679897
Comparison of 0.375% Ropivacaine and 0.25% Levobupivacaine for Infraclavicular Brachial Plexus Block
0.25% Levobupivacaine Versus 0.375% Ropivacaine: a Comparative Study in Ultrasound-Guided Infraclavicular Brachial Plexus Block
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 46 (actual)
- Sponsor
- Asan Medical Center · Academic / Other
- Sex
- All
- Age
- 19 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Infraclavicular brachial plexus block has been used more frequently with the development of high-resolution ultrasound. Compared with peripheral nerve block using landmark technique or nerve stimulator technique, ultrasound-guided peripheral nerve block decreases the required dose of local anesthetics. As the dose of the drug used decreases, the systemic toxic effects of local anesthetics are reduced. However, the decreased dose of the drugs might have influence on the onset time of local anesthetics. Thus, the investigator aimed to evaluated the onset time of the two equipotent local anesthetics, 0.375% ropivacaine and 0.25% levobupivacaine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ropivacaine solution | ultrasound-guided infraclavicular brachial plexus block with 0.375% ropivacaine solution |
| DRUG | Levobupivacaine solution | ultrasound-guided infraclavicular brachial plexus block with 0.25% levobupivacaine solution |
Timeline
- Start date
- 2018-09-18
- Primary completion
- 2018-12-07
- Completion
- 2018-12-08
- First posted
- 2018-09-21
- Last updated
- 2018-12-20
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03679897. Inclusion in this directory is not an endorsement.